Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aimovig
Pharma
FDA signs off on Pfizer's Zavypret, a nasal spray for migraine
Five months after acquiring Biohaven, Pfizer has scored FDA approval for one of the drugs gained in the purchase, migraine nasal spray Zavzpret.
Kevin Dunleavy
Mar 10, 2023 10:53am
Lilly finds stigma is one of the top problems for migraine
Jun 22, 2022 7:50am
Biohaven looks to expand migraine drug Nurtec to rhinosinusitis
Feb 22, 2022 11:16am
Amgen sees mid-single-digit CAGR growth to end of decade
Feb 8, 2022 2:30pm
Amgen's COVID-19 deal with Lilly helped amid drug slowdown
Feb 7, 2022 6:14pm
Novartis, Amgen settle their yearslong Aimovig dispute
Feb 1, 2022 11:41am
